标题
Cytokines in clinical cancer immunotherapy
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 120, Issue 1, Pages 6-15
出版商
Springer Nature
发表日期
2018-11-10
DOI
10.1038/s41416-018-0328-y
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation
- (2018) Rizwan Romee et al. BLOOD
- Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast Cancer
- (2018) Silvia C. Formenti et al. CLINICAL CANCER RESEARCH
- T-cell Homing Therapy for Reducing Regulatory T Cells and Preserving Effector T-cell Function in Large Solid Tumors
- (2018) Jiemiao Hu et al. CLINICAL CANCER RESEARCH
- Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
- (2018) Michael J. Overman et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase Ib trial of ALT-803, an IL-15 superagonist, plus BCG for the treatment of BCG-naïve patients with non-muscle-invasive bladder cancer.
- (2018) Charles Joel Rosser et al. JOURNAL OF CLINICAL ONCOLOGY
- ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
- (2018) John M Wrangle et al. LANCET ONCOLOGY
- TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
- (2018) Daniele V. F. Tauriello et al. NATURE
- Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
- (2018) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- M7824, a novel bifunctional anti-PD-L1/TGFβ Trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccine
- (2018) Karin M. Knudson et al. OncoImmunology
- Safety and clinical activity of 1L atezolizumab + bevacizumab in a phase Ib study in hepatocellular carcinoma (HCC).
- (2018) Stacey Stein et al. JOURNAL OF CLINICAL ONCOLOGY
- Pegilodecakin with nivolumab (nivo) or pembrolizumab (pembro) in patients (pts) with metastatic renal cell carcinoma (RCC).
- (2018) Nizar M. Tannir et al. JOURNAL OF CLINICAL ONCOLOGY
- Overall survival (OS) analysis of IMpower150, a randomized Ph 3 study of atezolizumab (atezo) + chemotherapy (chemo) ± bevacizumab (bev) vs chemo + bev in 1L nonsquamous (NSQ) NSCLC.
- (2018) Mark A. Socinski et al. JOURNAL OF CLINICAL ONCOLOGY
- NKTR-214 (CD122-biased agonist) plus nivolumab in patients with advanced solid tumors: Preliminary phase 1/2 results of PIVOT.
- (2018) Adi Diab et al. JOURNAL OF CLINICAL ONCOLOGY
- Effector CD8 + T cell-derived interleukin-10 enhances acute liver immunopathology
- (2017) Jessica Fioravanti et al. JOURNAL OF HEPATOLOGY
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- Cytokines in Cancer Immunotherapy
- (2017) Thomas A. Waldmann Cold Spring Harbor Perspectives in Biology
- Enhancement of antibody-dependent cellular cytotoxicity of cetuximab by a chimeric protein encompassing interleukin-15
- (2017) Maria Carmen Ochoa et al. OncoImmunology
- A safe and highly efficient tumor-targeted type I interferon immunotherapy depends on the tumor microenvironment
- (2017) Anje Cauwels et al. OncoImmunology
- Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines
- (2017) Christian Klein et al. OncoImmunology
- Modeling the receptor pharmacology, pharmacokinetics, and pharmacodynamics of NKTR-214, a kinetically-controlled interleukin-2 (IL2) receptor agonist for cancer immunotherapy
- (2017) Deborah Charych et al. PLoS One
- Safety, Antitumor Activity, and Immune Activation of Pegylated Recombinant Human Interleukin-10 (AM0010) in Patients With Advanced Solid Tumors
- (2016) Aung Naing et al. JOURNAL OF CLINICAL ONCOLOGY
- Antitumor effect of an adeno-associated virus expressing apolipoprotein A-1 fused to interferon alpha in an interferon alpha-resistant murine tumor model
- (2016) Marcos Vasquez et al. Oncotarget
- Identification of IFN-γ-producing T cells as the main mediators of the side effects associated to mouse interleukin-15 sustained exposure
- (2016) Marianna Di Scala et al. Oncotarget
- IL-10 expression defines an immunosuppressive dendritic cell population induced by antitumor therapeutic vaccination
- (2016) Diana Llopiz et al. Oncotarget
- TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity
- (2015) Claire Vanpouille-Box et al. CANCER RESEARCH
- Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
- (2015) L. Zhang et al. CLINICAL CANCER RESEARCH
- IL-35 and Autoimmunity: a Comprehensive Perspective
- (2015) Jinjung Choi et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- TRUCKs: the fourth generation of CARs
- (2015) Markus Chmielewski et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer
- (2015) Kevin C. Conlon et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Survival With GVAX Pancreas Prime and Listeria Monocytogenes–Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer
- (2015) Dung T. Le et al. JOURNAL OF CLINICAL ONCOLOGY
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic potential of chemokine signal inhibition for metastatic breast cancer
- (2015) Takanori Kitamura et al. PHARMACOLOGICAL RESEARCH
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal Models
- (2015) P. R. Rhode et al. Cancer Immunology Research
- Virotherapy with a Semliki Forest Virus–Based Vector Encoding IL12 Synergizes with PD-1/PD-L1 Blockade
- (2015) José I. Quetglas et al. Cancer Immunology Research
- The immunocytokine NHS-IL12 as a potential cancer therapeutic
- (2015) Jonathan Fallon et al. Oncotarget
- Targeting the Tumor Microenvironment with Interferon-β Bridges Innate and Adaptive Immune Responses
- (2014) Xuanming Yang et al. CANCER CELL
- Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy
- (2014) Carola H. Ries et al. CANCER CELL
- Ipilimumab Plus Sargramostim vs Ipilimumab Alone for Treatment of Metastatic Melanoma
- (2014) F. Stephen Hodi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Differential Requirement for IL-2 and IL-15 during Bifurcated Development of Thymic Regulatory T Cells
- (2014) Daniel Marshall et al. JOURNAL OF IMMUNOLOGY
- Therapeutic Activity of High-Dose Intratumoral IFN-β Requires Direct Effect on the Tumor Vasculature
- (2014) Robbert M. Spaapen et al. JOURNAL OF IMMUNOLOGY
- Myeloid-derived cells are key targets of tumor immunotherapy
- (2014) José Medina-Echeverz et al. OncoImmunology
- Evaluation of a novel CD20-targeted IL-15 immunotherapeutic with potent activity against B cell lymphoma
- (2014) Bai Liu et al. Journal for ImmunoTherapy of Cancer
- Interleukin-15 in Gene Therapy of Cancer
- (2013) Maria C. Ochoa et al. CURRENT GENE THERAPY
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Exploiting the curative potential of adoptive T-cell therapy for cancer
- (2013) Christian S. Hinrichs et al. IMMUNOLOGICAL REVIEWS
- Evaluation of Ipilimumab in Combination With Allogeneic Pancreatic Tumor Cells Transfected With a GM-CSF Gene in Previously Treated Pancreatic Cancer
- (2013) Dung T. Le et al. JOURNAL OF IMMUNOTHERAPY
- CSF-1R inhibition alters macrophage polarization and blocks glioma progression
- (2013) Stephanie M Pyonteck et al. NATURE MEDICINE
- High-density lipoproteins delivering interleukin-15
- (2013) Maria C. Ochoa et al. OncoImmunology
- Antitumor activity of an immunocytokine composed of an anti-GD2 antibody and the IL-15 superagonist RLI
- (2013) Marie Vincent et al. OncoImmunology
- Antitumor Immunotherapeutic and Toxic Properties of an HDL-Conjugated Chimeric IL-15 Fusion Protein
- (2012) M. C. Ochoa et al. CANCER RESEARCH
- A Phase I Dose-Finding Trial of Recombinant Interleukin-21 and Rituximab in Relapsed and Refractory Low Grade B-cell Lymphoproliferative Disorders
- (2012) J. M. Timmerman et al. CLINICAL CANCER RESEARCH
- Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease
- (2012) Bin Gao JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The Fusion Protein of IFN- and Apolipoprotein A-I Crosses the Blood-Brain Barrier by a Saturable Transport Mechanism
- (2012) J. Fioravanti et al. JOURNAL OF IMMUNOLOGY
- Targeting the TGFβ signalling pathway in disease
- (2012) Rosemary J. Akhurst et al. NATURE REVIEWS DRUG DISCOVERY
- U.S. Food and Drug Administration Approval: Peginterferon-alfa-2b for the Adjuvant Treatment of Patients with Melanoma
- (2012) T. M. Herndon et al. ONCOLOGIST
- IL-10 Elicits IFNγ-Dependent Tumor Immune Surveillance
- (2011) John B. Mumm et al. CANCER CELL
- Direct Effects of Type I Interferons on Cells of the Immune System
- (2011) S. Hervas-Stubbs et al. CLINICAL CANCER RESEARCH
- Anchoring interferon alpha to apolipoprotein A-I reduces hematological toxicity while enhancing immunostimulatory properties
- (2011) Jessica Fioravanti et al. HEPATOLOGY
- IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors
- (2011) Sid P. Kerkar et al. JOURNAL OF CLINICAL INVESTIGATION
- Safety and Clinical Effect of Subcutaneous Human Interleukin-21 in Patients with Metastatic Melanoma or Renal Cell Carcinoma: A Phase I Trial
- (2010) H. Schmidt et al. CLINICAL CANCER RESEARCH
- Successful Colon Cancer Eradication after Chemoimmunotherapy Is Associated with Profound Phenotypic Change of Intratumoral Myeloid Cells
- (2010) J. Medina-Echeverz et al. JOURNAL OF IMMUNOLOGY
- Dual targeting of CCR2 and CCR5: therapeutic potential for immunologic and cardiovascular diseases
- (2010) Qihong Zhao JOURNAL OF LEUKOCYTE BIOLOGY
- Antitumoral efficacy of DNA nanoparticles in murine models of lung cancer and pulmonary metastasis
- (2009) M Rodrigo-Garzón et al. CANCER GENE THERAPY
- Advances in Interleukin-12 Gene Therapy for Acquired Liver Diseases
- (2009) Pedro Berraondo et al. CURRENT GENE THERAPY
- TGFβ in Cancer
- (2008) Joan Massagué CELL
- Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma
- (2008) Adil I. Daud et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started